Beruflich Dokumente
Kultur Dokumente
Pharmaceutical Contract
Manufacturing and Research
Pharmaceu
L
ti
Manufacturi cal Contract
arge pharmaceutical companies increasingly turn to contract manufacturing or- ng and Rese
arch
ganizations (CMOs) solely to achieve efficiencies in cost, capacity and time-to-
market, or to obtain a specific expertise not available in-house. Today, these factors
still play a role, but now the most dynamic driver behind the use of CMOs in the phar-
maceutical industry rapidly is becoming the unique, innovative, and state-of-the-art
process and production technology they offer. More and more pharma companies
are leaning towards outsourcing to concentrate on marketing their products, without
spending time in drug discovery and process of manufacturing. This applies to those
virtual companies that exist by the simple fact they can rely on contract manufactur-
ers and researchers.This BCC study looks at almost all types of contracting models
and contracting companies. The rapid development of technologies and major chang-
es in market behavior justify focusing on this segment. The report provides an over- sales@bc
www.bccr
cresearch
esearch.c
.com
om
view of contract manufacturing and research in the pharmaceutical and examines
contracting models and the history of and need for outsourcing. The contract com-
panies manufacturing and researching pharmaceuticals and biopharmaceuticals are
brought to the forefront and described in terms of industry structure and where they
are placed in the present scenario.
Why Choose BCC Research Reports?
Scope of Study Experience You Can Trust
BCC Research has over 35 years reporting on top industries
The scope of this report is broad, and contains:
An overview of the contract in the pharmaceutical industry Market Data You Can Rely Upon
Analysis of the quality assurance required, the regulatory environment and BCC reports are written by independent analysts who are
technology transfer aspects industry experts
An overview of technological issues and trends Valuable Insights You Can Invest In
Examination of the markets size by specific drug with forecasts through 2009 Market research from BCC provides superior value-to-cost
Revenue analysis by bulk drugs and dosage forms like solids, liquids and versus lengthy internal analysis or outside consultants
semisolids, and separately for OTC and nutritional products
Analysis of the contract research market, with forecasts through 2009
Company profiles and market shares, where available. Place your order NOW!
Pharmaceutical Contract Manufacturing and Research
Phone: 866-285-7215
Report Highlights Report ID: PHM043A Published: May 2005 Price: $3950
Worldwide revenue for contract manufacturing and research for the
pharmaceutical industry was estimated at $100 billion in 2004 and is expected
to rise at an average annual growth rate (AAGR) of 10.8% to $168 billion in
2009.
Contract manufacturing of prescription drugs for 2004 was estimated at $26.2
billion, and is expected to rise to $43.9 billion by end of 2009.
Operations Office Corporate Office
Contract manufacturing of OTC and nutritional products is the largest and 70 New Canaan Avenue 40 Washington Street, Suite 110
fastest growing segment, expected to rise at an AAGR of 11.3% to $102 billion Norwalk, CT 06855 USA Wellesley, MA 02481 USA
by 2009. T: 866-285-7216 (cust. svc.) T: 866-285-7215 (sales)
The contract research market is expected to reach $21.9 billion by 2009, rising F: 203-229-0087 F: 781-489-7308
at an AAGR of 8.6% from $ 14.5 billion in 2004. sales@bccresearch.com
www.bccresearch.com
Pharmaceutical Contract Manufacturing and Research PHM043A ABOUT BCC RESEARCH
BCC Research is a leading information resource producing
high-quality market research reports, newsletters, and
conferences. BCCs information products explore major
market, economic, scientific, and technological developments
SUMMARY TABLE for business leaders in industrial, pharmaceutical, and high
WORLDWIDE REVENUE OF PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH technology organizations. Industry analysis and market
ORGANIZATIONS, THROUGH 2009
forecasts for advanced materials, high-tech systems
($ BILLIONS)
and components, nanotechnology and novel processing
AAGR% methods are at the forefront of the companys expertise. The
Market Segment 2002 2003 2004 2009 2004-2009 company publishes daily, monthly, bi-monthly, and quarterly
Contract manufacturing of bulk and dosage form drugs 21.4 23.8 26.2 43.9 10.9 subscription-based newsletters in such areas as energy,
Contract manufacturing of OTC and nutritionals 48.6 54.2 59.8 102.0 11.3 environmental, fuel cells, and transportation. For more than
Contract research 12.5 13.2 14.5 21.9 8.6
35 years, BCCs in-depth market analysis has provided
Total 82.5 91.2 100.5 167.8 10.8
businesses with the insight needed to make intelligent and
Source: BCC Research strategic business decisions.